About RENEUBIO INC.
ReneuBio is a biotechnology company that provides AlphaForge, a platform designed to predict and mitigate clinical risks in small-molecule drug development by identifying structural and biological liabilities early in the process. The platform helps pharmaceutical and biotech companies make informed decisions to reduce development costs and failure rates.
Clinical risk prediction for small-molecule programsStructural liability detectionTargeted molecular redesignEvaluation of molecules in the context of structure, biology, and disease settingHigh-stakes decision support across the drug lifecycle
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to RENEUBIO INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.